Press Releases
- Sarepta Therapeutics to Present at the 2020 RBC Capital Markets Virtual Global Healthcare Conference05/12/2020
- Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases05/11/2020
- Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments05/06/2020
How Sarepta Infused its Corporate Brand with Urgency and Optimism on Behalf of Patients
"Armed with the most advanced science in genetic medicine, we are in a daily race to rescue lives otherwise stolen by rare disease. At Sarepta, every day is another 24 hours to stand up for patients, advance technology, challenge convention and drag tomorrow into today."
News Features
Media Library
Press Contact
Tracy Sorrentino
Senior Director, Public Relations
Sarepta Therapeutics, Inc.
[email protected]
617-274-4052